KCI BioTech Overview
- Year Founded
-
2016
- Status
-
Private
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$6.99M
- Investors
-
5
KCI BioTech General Information
Description
Provider of CRO service designed for pharmacodynamic research. The company focuses on experimental animal models in cardiovascular and cerebrovascular diseases, inflammation, immune and metabolic diseases, liver and kidney diseases, and other non-tumor diseases, proving reliable evaluation data for more emerging treatment technologies.
Contact Information
Website
www.kcibiotech.comCorporate Office
- Room 501, NW-12, Nanopolis Suzhou
- No.99 Jinji Lake Avenue
- Suzhou, Jiangsu 215021
- China
Corporate Office
- Room 501, NW-12, Nanopolis Suzhou
- No.99 Jinji Lake Avenue
- Suzhou, Jiangsu 215021
- China
KCI BioTech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC (Series B) | 30-Jun-2023 | $6.99M | Completed | Generating Revenue |
KCI BioTech Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eastern Biopharmaceuticals | Corporation | Minority | ||
| Guoqian Venture Capital | Venture Capital | Minority | ||
| Jiangsu Tongren Boda Private Equity Fund Management | Venture Capital | Minority | ||
| Suzhou Oriza Holdings Corporation | Asset Manager | Minority | ||
| Suzhou Zhongxin Innovation Investment Management | Venture Capital | Minority |
KCI BioTech FAQs
-
When was KCI BioTech founded?
KCI BioTech was founded in 2016.
-
Where is KCI BioTech headquartered?
KCI BioTech is headquartered in Suzhou, China.
-
What industry is KCI BioTech in?
KCI BioTech’s primary industry is Laboratory Services (Healthcare).
-
Is KCI BioTech a private or public company?
KCI BioTech is a Private company.
-
What is KCI BioTech’s current revenue?
The current revenue for KCI BioTech is .
-
How much funding has KCI BioTech raised over time?
KCI BioTech has raised $6.99M.
-
Who are KCI BioTech’s investors?
Eastern Biopharmaceuticals, Guoqian Venture Capital, Jiangsu Tongren Boda Private Equity Fund Management, Suzhou Oriza Holdings Corporation, and Suzhou Zhongxin Innovation Investment Management have invested in KCI BioTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process